Contact Us - NEW API TECHNOLOGIES

API Flash News

Beta selective blocking agent: Landiolol

Iodine based contrasting agent: IOMEPROL

ALK Rearranged lung cancer: Ensartinib

Treatment of cystic fibrosis: Vanzacaftor

FDA GRANTS ACCELERATED APPROVAL PIRTOBRUTINIB

Oral ER degrader: Elacestrant

A novel drug for activated phosphoinositide-3 kinase delta syndrome: Leniolisib

CAPIVASERTIB: Treatment for cancer

A Potential sodium-glucose co-transporter 2 (SGLT2) inhibitor: BEXAGLIFLOZIN

Back To Top